Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/133595
DC FieldValue
dc.titleReiter's disease, responding to methotrexate
dc.contributor.authorChee, Y.C.
dc.contributor.authorChan, H.L.
dc.date.accessioned2016-12-20T08:37:53Z
dc.date.available2016-12-20T08:37:53Z
dc.date.issued1977
dc.identifier.citationChee, Y.C., Chan, H.L. (1977). Reiter's disease, responding to methotrexate. Singapore Medical Journal 18 (2) : 136-138. ScholarBank@NUS Repository.
dc.identifier.issn00375675
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/133595
dc.description.abstractNo specific therapy exists for Reiter's disease. Urethritis is usually treated with a course of tetracycline though the aetiological agent remains obscure. Drug treatment for arthritis consists of phenylbutazone or indomethacin; corticosteroid therapy is indicated only when the disease is progressive and this is usually associated with severe keratoderma and marked weight loss. Farber et al (1967) reported the successful use of methotrexate in patients with Reiter's disease, particularly those with crippling and incapacitating arthritis. In this report, methotrexate was exhibited primarily to control the keratoderma blenorrhagica in a man of 34 which markedly improved.
dc.typeArticle
dc.contributor.departmentMEDICINE
dc.description.sourcetitleSingapore Medical Journal
dc.description.volume18
dc.description.issue2
dc.description.page136-138
dc.description.codenSIMJA
dc.identifier.isiutNOT_IN_WOS
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.